. Analogs that carried more or fewer negative charges on the precision polymer moiety or that had a lowermolecular-weight precision polymer attached exhibited significantly less potency and shorter duration of action when tested at similar doses (G. Kochendoer The zebrafish is an attractive model organism for studying cancer development because of its genetic accessibility. Here we describe the induction of clonally derived T cell acute lymphoblastic leukemia in transgenic zebrafish expressing mouse c-myc under control of the zebrafish Rag2 promoter. Visualization of leukemic cells expressing a chimeric transgene encoding Myc fused to green fluorescent protein (GFP) revealed that leukemias arose in the thymus, spread locally into gill arches and retro-orbital soft tissue, and then disseminated into skeletal muscle and abdominal organs. Leukemic cells homed back to the thymus in irradiated fish transplanted with GFP-labeled leukemic lymphoblasts. This transgenic model provides a platform for drug screens and for genetic screens aimed at identifying mutations that suppress or enhance c-mycinduced carcinogenesis.
The zebrafish (Danio rerio) is a potentially valuable vertebrate system in which to elucidate novel molecular pathways of oncogenesis. In particular, this model organism develops an array of benign and malignant tumors resembling those in humans (1, 2) and is amenable to large-scale forward genetic screens that could be targeted to conserved cancer pathways (3, 4) . However, it has not been possible to establish stable lines of transgenic tumor-bearing fish. Here we report the induction of T cell leukemia in zebrafish, using mouse c-myc (mMyc) and chimeric EGFP-mMyc transgenes (5) under control of the zebrafish Rag2 promoter (zRag2), which targets gene expression specifically to lymphoid cells (6) . This transgenic strategy is based on the demonstrated role of MYC in the pathogenesis of human T and B cell leukemias and lymphomas and its ability to induce T and B lymphoid malignancies when aberrantly expressed in transgenic mice [reviewed in (7, 8) ].
We microinjected wild-type zebrafish embryos with the zRag2-mMyc or zRag2-EGFPmMyc transgene at the one-cell stage of development (9), generating F 0 founder fish mosaic for expression of the transgene (10) . Of 215 mosaic F 0 zebrafish embryos injected with zRag2-mMyc, 11 (5%) developed tumors, as did 7 (6%) of 122 injected with zRag2-EGFP-mMyc. These results are similar to the proportion of embryos expressing green fluorescent protein (GFP) in developing thymocytes after injection of the control zRag2-GFP reporter construct, suggesting that cancer develops in nearly every mosaic fish whose lymphoid progenitors carry a functional mMyc transgene. The mean latencies of tumor development in zRag2-mMyc ϩ and zRag2-EGFP-mMyc ϩ fish were 44 and 52 days (range, 30 to 131 days), respectively.
The affected zebrafish had distended abdominal cavities and splayed eyes due to retro-orbital infiltration by malignant cells (compare Fig. 1 To establish the extent of leukemic cell infiltration, we studied tissue sections from seven diseased fish. Lymphoblasts almost completely effaced the kidney marrow [the site of definitive hematopoiesis in the fish (Fig. 1 , G and H)] and were found between the fibers of skeletal muscle (fig. S1, E and F). Leukemic cell invasion was also observed in the gut, gills, and fins, and it was especially prominent in the region adjacent to the olfactory bulb. Although zebrafish Rag genes are expressed at the apical surface of the olfactory placode (6, 11) , malignant cells in the olfactory region did not express ␣-keratin and exhibited lymphoblast morphology, demonstrating that they were lymphoid and not epithelial in origin.
To analyze the gene expression patterns in transformed lymphoblasts, we applied RNA in situ hybridization to paraffin-embedded sections from seven leukemic F 0 fish, testing for expression of the T cell-specific gene zLck, the B cell-specific immunoglobulin heavy-chain (zIgM) and light-chain (zIgLC) genes (12) , the early lymphoid genes zRag1 and zRag2, and mMyc. Each of the leukemias expressed mMyc (fig. S3, A and E), zRag2  (fig. S3, B and F) , zRag1 (13) , and zLck ( fig.  S3 , C and G), but not zIgM or zIgLC, confirming expression of the transgene and the derivation of these leukemias from cells of the T lymphoid lineage.
We further investigated the clonality and lineage of the lymphoblasts by Southern blot analysis of restriction enzyme-digested leukemic cell DNAs, using radiolabeled probes for zTcr-␣ (12) and zIgM constant regions. Of the three leukemias analyzed, one had monoclonal and one had oligoclonal zTcr-␣ gene rearrangements ( Fig. 2A) . The third showed a germ line zTcr-␣ configuration, but very strong zLck RNA expression, verifying the thymic origin of the lymphoblasts and suggesting that transformed thymocytes in this fish were developmentally arrested at a stage before zTcr-␣ gene rearrangement. None of the leukemias had rearranged zIgM genes. In addition, flow cytometric measurements of the DNA content of tumor cells from a zRag2-EGFP-mMyc fish showed that this Myc-induced tumor was clonally aneuploid (Fig. 2B) . Taken together, these data indicate that Myc-induced leukemias in the zebrafish represent the clonal expansion of transformed T lymphocyte precursors and suggest that additional mutations are needed to produce the malignant phenotype.
To quantify the extent of leukemic cell infiltration of the kidney and spleen, we analyzed hematopoietic cells from these tissues by fluorescence-activated cell sorting (FACS) (14) . In wild-type zebrafish, the kidney (n ϭ 7) contained (8.4 Ϯ 3.7) ϫ 10 5 (mean Ϯ SD) blood cells, and the spleen (n ϭ 6) contained (8.2 Ϯ 6.3) ϫ 10 4 blood cells; these wild-type values were about one-sixth that of leukemic fish [kidney (n ϭ 5), (4.95 Ϯ 3.3) ϫ 10 6 blood cells; spleen (n ϭ 4), (4.64 Ϯ 1.5) ϫ 10 5 blood cells]. The leukemic blasts comprised ϳ87% of the kidney marrow cells and had a granularity similar to that of normal lymphocytes (y axis in Fig. 3 ), although they were slightly larger in size (x axis in Fig. 3 ). This analysis of the kidney marrow, the equivalent of mammalian bone marrow (15) (16) (17) , supports the histopathological classification of these Myc-induced cancers as T cell acute leukemia rather than disseminated lymphoma, in which the blast cells account for Ͻ30% of the total cells in the marrow. To assess the transplantability of zebrafish leukemic cells, we first injected the zRag2-mMyc transgene into fertilized eggs from a stable transgenic zRag2-GFP line, so that the lymphoblasts would be GFP positive when leukemia developed. GFP-positive lymphoblasts from a leukemic 62-day-old fish were then transplanted intraperitoneally into eight irradiated wild-type adult zebrafish. Leukemic cells were apparent at the site of transplantation within 7 days after injection (Fig. 4A) and had begun to spread throughout the peritoneal cavity within 14 days after injection (Fig. 4B) . Lymphoblast homing to the thymus occurred relatively early in the disease process ( fig. S6B) , with GFPpositive cells becoming evident at this site in one fish within 14 days after injection and in six fish within 26 days after injection. There was also prominent leukemic cell infiltration into the region adjacent to the olfactory bulb in two fish within 14 days after injection and in all eight within 26 days after injection ( fig. S6, C and D) . These experiments establish the transplantability of Myc-induced leukemias in zebrafish, indicate that the disseminated spread of leukemic cells proceeds along anatomically defined pathways, and suggest that the region adjacent to the olfactory bulb is a preferred site for the homing of immature T cells.
The power of the zebrafish model lies in its ability to accommodate "forward-genetic" screens to identify modifier genes that influence the development of Myc-induced leukemia, an application requiring a stable transgenic zebrafish line that expresses the mMyc transgene. Thus, mosaic zRag2-EGFP-mMyc F 0 fish injected as single-cell embryos were mated, and the F 1 offspring of one fish developed leukemia with a mean latency of 32 days (range of 21 to 44 days). GFP fluorescence was readily detectable in the thymic lymphoblasts of these fish (Fig. 4, D through  F) , demonstrating germline transmission and expression of the chimeric transgene.
The rapid onset of leukemia after germline transmission of the transgene made it necessary to propagate this stable line by in vitro fertilization (IVF). Hence, we killed 90-day-old leukemic males and used their sperm to fertilize eggs from normal females. The resultant progeny showed expansion of GFP-positive leukemic cells from the thymus by 1 month of age. Technology to render the expression of transgenic myc alleles that are regulatable with estrogen has been developed for in vivo use in the mouse (18) , and we are currently testing this approach for its capacity to generate large numbers of transgenic fish for further genetic manipulations, thus eliminating the need for IVF procedures.
Modifier screens in the mouse have identified retrovirally activated genes that accelerate Myc-induced oncogenesis (19) , and breeding studies with genetically manipulated mice have identified other critical interact- ing oncogenes and tumor suppressors (20, 21) . More recent studies in murine models have exploited tissue-specific, regulatable expression of myc alleles to show that myc expression is essential not only for establishment of the leukemic phenotype, but also for maintenance of the malignant phenotype (22, 23) . Despite these advances, it has been difficult to conduct unbiased screens in the mouse to identify modifier genes whose inactivation delays or prevents the ability of Myc to generate a malignant phenotype. This obstacle could be overcome by conducting genomewide zebrafish screens for germline mutations induced by either ethylnitrosourea or retroviral integration. Such strategies would also be especially attractive for identifying tumor suppressor genes, as the mutant fish would carry inactivating mutations of single tumor suppressor alleles throughout development, increasing the likelihood of acquiring inactivating mutations or deletions affecting both alleles of the same gene. Such mutations may shed new light on the molecular mechanisms that drive T cell leukemia and other human cancers to which Myc has been linked (24 ) . Others have demonstrated the utility of living zebrafish as subjects of screens for small molecules that perturb normal development (25, 26 ) . Thus, our transgenic zebrafish model may also provide the opportunity to conduct large-scale screens for new drugs for the prevention and treatment of leukemia. Kenneth J. Hillan, 3 Napoleone Ferrara 1 †
The vascular endothelium was once thought to function primarily in nutrient and oxygen delivery, but recent evidence suggests that it may play a broader role in tissue homeostasis. To explore the role of sinusoidal endothelial cells (LSECs) in the adult liver, we studied the effects of vascular endothelial growth factor (VEGF) receptor activation on mouse hepatocyte growth. Delivery of VEGF-A increased liver mass in mice but did not stimulate growth of hepatocytes in vitro, unless LSECs were also present in the culture. Hepatocyte growth factor (HGF) was identified as one of the LSEC-derived paracrine mediators promoting hepatocyte growth. Selective activation of VEGF receptor-1 (VEGFR-1) stimulated hepatocyte but not endothelial proliferation in vivo and reduced liver damage in mice exposed to a hepatotoxin. Thus, VEGFR-1 agonists may have therapeutic potential for preservation of organ function in certain liver disorders.
The vascular endothelium is a highly versatile system and, in addition to its well-established function of nutrient and gas exchange between tissues and blood, it plays multiple homeostatic roles (1) . Furthermore, the endothelium has an inductive effect on liver (2) and pancreas (3) development before the establishment of a blood flow. Vascular endothelial growth factor-A (VEGF-A) (4), a major regulator of normal and pathological angiogenesis, binds to two tyrosine kinase receptors, VEGFR-1 (Flt-1) (5) and VEGFR-2 (KDR/Flk-1) (6, 7). VEGFR-2 is the major mediator of the mitogenic, angiogenic, and permeability-enhancing effects of VEGF-A (8). However, many conflicting reports about the function of VEGFR-1 exist. This receptor has been implicated in the inhibition of VEGF-dependent endothelial mitogenesis and chemotaxis by several mechanisms (9-11). Other studies have shown that VEGFR-1 mediates monocyte chemotaxis (12) , recruitment of endothelial cell progenitors (13) , and survival of hematopoietic stem cells (14) . VEGFR-1 activation also has been reported to result in collateral vessel growth through recruitment of bone marrow-derived cells (15) . Thus, the importance of VEGFR-1 signaling in the vascular endothelium is largely unclear. We sought to investigate the effects of VEGFR activation on parenchymal cell proliferation and survival. To achieve sustained systemic levels of VEGF, we injected Chinese hamster ovary (CHO) cells expressing VEGF 165 or control CHO cells into the legs of nude mice (16). We observed substantially increased liver sizes in the CHO-VEGF groups. The liver/brain ratio (that is, the relative liver mass) of the CHO-VEGF group (4.73 Ϯ 0.39) was significantly increased compared with that of the CHO-dihydrofolate reductase (CHO-DHFR) (3.18 Ϯ 0.25; P Ͻ 0.0001) and CHO-Hakata antigen (CHO-HAg) (3.00 Ϯ 0.45; P Ͻ 0.0001) controls. This reflects an increase in relative liver masses of 49% and 59%, respectively.
Histological analysis of the livers of 
Myc-Induced T Cell Leukemia in Transgenic Zebrafish

